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ATTEMPT TO PURIFY THE NORMAL CELLULAR ISOFORM OF 
PRION PROTEIN FROM MOUSE AND HAMSTER BRAIN . . 
M. Cerom. J. Q&& LCNSS, NINDS NIH, Bethesda, 
MD 20892; Institute of Neurology, University of Pavia, Italy. 
Recent developments in genetics and mole.cular biology of spongiform 
encephalophaties @ion diseases) confirm the key role of scrapie amyloid 
@ion) protein in susceptibility, disease transmission, incubation time and 
pathogenesis. The abnormal isoform of scrapie amyloid precursor (prion 
protein, PrPsc) is derived from a normal cellular protein (PrF) through a 
post-translational modification and/or conformational change. The 
conversion of PrF into Prpsc is a fundamental step in the patiogenesis, and 
therefore the comparison of Prpc and Prfl native conformations is essential 
to understand the molecular mechanism of prion-induced diseases. 
PrPC was enriched in mouse brain homogenate by differential 
centrifugations and extraction with T&on-Xl 14. The resulting phospholipid- 
rich phase was digested by phosphatidylinositol-specific phospholipase C 
(PIPLC). Supematanrs containing PIPLC-released Pr@ were separated by 
immobilized Cu++ ion affinity chromatography and cation exchange 
chromatography; a certain degree of purification was obtained but yields 
were low. Our results suggest that PIPLC-released Pr@ is not as hydrophilic 
as previous studies have suggested. Even after enzymatic cleavage of the 
glycolipid anchoring PrF to membranes, PrK tends to associate with 
phospholipids and to aggregate. Additional chromatographic steps in the 
presence of nondenaturing detergents are necessary to increase the yield of 
PrPc. 
Diagnosis 
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CRITERIA FOR DIAGNOSIS OF PURE ALZHEIMBR’S DISEASE 
A. Wallin, K. Blennow and P. Scheltens. University of Giiteborg, Dept. 
of Clinical Neuroscience, Section of Psychiany and Neurochemistry, 
Mtilndal Hospital, S-431 80 Mblndal, Sweden, and Dept. of Neurology, 
Free University Hospital, Amsterdam, The Netherlands 
Today, the clinical diagnosis of Alzheimer’s disease (AD) is made 
using exclusion crite.ria and symptomatological criteria that are not well 
defined. Markers for the underlying pathological processes are not taken 
into account. This involves a risk that the critexia delimit a hetemgenous 
group bf patients. The limit against vascular dementia in particular is 
poorly defined. We suggest a diagnosis made by weighing together the 
results of a symptom analysis called Stepwise Comparative Status 
Analysis (STEP) and evidence provided by various biological markers. 
We have been able to identify two types of AD. AD type I or ‘pure’ AD 
is characterized by a cortical degeneration of neurons and their synapses. 
AD type II, or ‘senile dementia of the Aizheimer type’, ia cb;uactelizti 
by several different types of pathological processes, not only the cortical 
degeneration typical of AD type I, but also vascular changes, e.g. white- 
matter lesions. For ‘pure’ AD we have worked out diagnostic criteria 
that are currently in press. In short, these criteria include presence of 
instrumental deficits and memory disturbances and absence of significant 
radiologically detectable white-matter lesions. It is our hope that these 
mom specific AD criteria that take into account the underlying 
pathological processes Fll be used in clinical drug trials and in 
pathophysiological AD research. 
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THE CLINICAL DlAGNOSlS OF VASCUL4R DEMENTIA: 
A COMPARISON BETWEEN SEVEN CURRENTLY USED DIAGNOSTIC CRITERIA. 
FRJ Verhey*, N Rozendaal, J Jolles. 
Academic Psychiatric Centre, Dept. Psychiatry & Neuropsychology. University of 
Limburg, P.O. Box 616; 6200 MD Maastricht, The Netherlands. 
Since the introduction of the lschemic Scale (IS) of Hachinski et al. in 1974, 
several clinical criteria for the differentiation between Alzheimers disease (AD) and 
Vascular dementia (VaD) have been proposed. These are: the modified IS of Rosen 
et al. (1980) and of Loeb (1983), those outlined by DSM-III (-R) (1980) and 
Erkinjuntii et al. (1987), and the recent consensus-criteria of the ADDTC (Chui et 
al., 1992) and of the NINDS-AIREN (Roman et al., 1993). In the present study, we 
applied these seven difeerent sets of criteria for VaD to a sample of demented 
outpatients visiting the Maastricht Memory Clinic, in order to compare prevalence 
rates, and to investigate the level of (dis)agreement between the criteria. 
The data of 109 consecutively referred patients (mean age 70.1 yrs.) with mild 
to moderate dementia were evaluated. Patients with somatic or psychiatric 
disorders other than primary degenerative of cerebrovascular disorders were 
excluded from this study. 
The percentage of patients diagnosed as VaD varied between 33% -using the IS 
of Rosen et al.- and 7%, according to the NINDS-AIREN criteria. The percentage of 
patients diagnosed as AD ranged between 54.75% -using the DSM-III-R or the 
NINDS-AIREN criteria for the exclusion of VaD respectively. Depending of the 
criteria used, the percentage of unclassified patients ranged from 2.32%. The 
agreement with regard to the diagnosis of VaD between the different criteria was 
only slight to modest (overall kappa: 0.48), whereas the agreement with regard to 
the diagnosis of AD was substantial (overall kappa: 0.71). 
We conclude that the prevalence of VaD depends to a large extent on the criteria 
that have been used. For the exclusion of VaD for the diagnosis of AD, the choice is 
much less critical. 
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DEMENTIA DIAGNOSIS IN PRIMARY CARE: RESULTS OF A 
REPRESENTATIVE SURVEY IN SOUTHERN LOWER SAXONY, 
GERMANY. J. Staedt, G. Stoppe, H. Sandholzer’. S. Winter, J. Kiefer, M. 
Kochen’, E. Riither. Depts. of Psychiatry and General Practice*, University 
of Goettmgen, 37075 Goettingen, Germany. 
Since primary care physicians play the most important role for diagnosis 
and therapeutic management (at least in the early phase) of patients with 
senile dementive disorders. we performed a survey to investigate on 
diagnostic accuracy 
We used two case vignettes, each describing a 7Oyear old widow 
complaining memory problems. In case 1 these problems were slight and 
unspecific, in case II there were typical histories and characteristics of 
moderate dementia of either Alzheimer’s type (SDAT; Ilb) or Multi - infarct - 
type (MID, IIa)). In addition case I had no cerebrovascular risk factors, 
whereas case 2 had. These case vignettes were randomly assigned to 145 
general practitioners and 14 neuropsychiatrists in primary care (response rate 
overall 83.2%). Trained interviewers asked for diagnostic and differential 
diagnostic considerations. 
Main results are: Impairment of cerebral blood flow was considered most 
frequently to be the cause of the disorder, independently from the presence of 
cerebrovascular risk factors. SDAT was correctly diagnosed in 25.9% in case 
Ilb, MID was diagnosed in 37.2% in case IIa. Adverse drug effects were 
considered for (differential) diagnosis only by a minority of the physicians 
(I.!%), In case I, 57.8% of the physicians considered depression for 
diagnosis or differential diagnosis with the neuropsychiatrists doing that 
signiticantly more often (78.6% for differential diagnosis) than the general 
practitioners. 
In conclusion, dementia is widely underdiagnosed in primary care. 
Cerebrovascular mechanisms are conceptualized as main reasons for 
dementia. Education in primary care should also focus on the fact, that 
treatable causes of dementia like adverse drug e&cts and depressjon are 
underdiagnosed, which may have major consequences on health care in old 
age. It would be interesting to replicate this study in other countries with 
other education and health care systems. 
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THE COGNITIVE BATTERY FOR DEMENTIA IN THE DIAGNOSIS OF 
ALZHEIMER’S DISEASE. K.J. Christensen, J.R. McCarten. S.J. Rottunda. 
and BE Riley. Geriat. Res. Educ. Clin. Ctr., VA Med. Ctr., and Depts. of 
Neurology and Psychology, University of Minnesota, Minneapolis, MN 
55417 USA. 
The purposeof this study was to determine whether profile analysis using 
the Cognitive Battery for Dementia (CBD) can improve diagnostic accuracy 
in Alzheimer’s disease (AD). The CBD was developed to provide reliable 
measurement of six cognitive abilties throughout the performance range of 
moderately severe dementia patients to healthy older adults. Profile analysis 
provides a quantitative means of evaluating the similarity of an individual 
patient’s pattern of cognitive test results to that of the average pattern seen in 
patients with probable AD. In an initial study of 31 patients with antemortem 
diagnoses of probable AD, four patients had cognitive profiles that were 
